The Science Behind Our BPC 157 Peptide Should You Take BPC 157 Peptides? 2026 predictions: historic FDA shift, plausible mechanisms, bespoke tx, RFK Jr., biotechs, state AGs, peptides, embryos The Niche Hims & Hers stock rises as FDA schedules peptide review BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved